CareDx logo.jpg
CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction
May 18, 2022 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx
May 17, 2022 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference
May 11, 2022 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
CareDx Reports First Quarter 2022 Results
May 05, 2022 16:01 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection
May 05, 2022 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award
April 28, 2022 10:45 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
CareDx Extends Artificial Intelligence Leadership to Heart Transplantation
April 28, 2022 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
CareDx to Report First Quarter 2022 Financial Results
April 27, 2022 16:01 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
International Society for Heart and Lung Transplantation Foundation Selects Reg Seeto as Corporate Chair
April 27, 2022 09:15 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx logo.jpg
CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings
April 22, 2022 07:00 ET | CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...